CoChat

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer

Open access
Barbier-Torres, Lucía, Delgado, Teresa C., García-Rodríguez, Juan L., Zubiete-Franco, Imanol, Fernández-Ramos, David, Buqué, Xabier, Cano, Ainara, Juan, Virginia Gutiérrez-de, Fernández-Domínguez, Itziar, Lopitz-Otsoa, Fernando, Fernández-Tussy, Pablo, Boix, Loreto, Bruix, Jordi, Villa, Erica, Castro, Azucena, Lu, Shelly C., Aspichueta, Patricia, Xirodimas, Dimitris, Varela-Rey, Marta, Mato, José M., Beraza, Naiara, Martínez-Chantar, María L. · 2015 · Oncotarget
Cited by 87

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

// Lucía Barbier-Torres 1 , Teresa C. Delgado 1 , Juan L. García-Rodríguez 1 , Imanol Zubiete-Franco 1 , David Fernández-Ramos 1 , Xabier Buqué 2 , Ainara Cano 3 , Virginia Gutiérrez-de Juan 1 , Itziar Fernández-Domínguez 1 , Fernando Lopitz-Otsoa 1 , Pablo Fernández-Tussy 1 , Loreto Boix 4,5 , Jordi Bruix 4,5 , Erica Villa 6 , Azucena Castro 3 , Shelly C. Lu 7 , Patricia Aspichueta 2 , Dimitris Xirodimas 8 , Marta Varela-Rey 1 , José M. Mato 1 , Naiara Beraza 1 and María L. Martínez-Chantar 1 1 CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Bizkaia Science and Technology Park, Derio, Bizkaia, Spain 2 Department of Physiology, University of the Basque Country UPV/EHU, Faculty of Medicine and Dentistry, Leioa, Bizkaia, Spain 3 OWL, Bizkaia Science and Technology Park, Derio, Bizkaia, Spain 4 Barcelona-Clínic Liver Cancer Group, Institut d’Investigacions Biomèdiques August Pi I Sunyer, Liver Unit, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain 5 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain 6 Department of Gastroenterology, Azienda Ospedaliero-Universitaria & University of Modena and Reggio Emilia, Modena, Italy 7 Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USC Research Center for Liver Diseases, Keck School of Medicine, Los Angeles, CA, USA 8 Centre de Recherche de Biochimie Macromoléculaire, Montpellier, France Correspondence: María L. Martínez-Chantar, email: // Keywords : Neddylation; Cancer metabolism; Hepatocellular Carcinoma; LKB1; Akt Received : September 26, 2014 Accepted : December 10, 2014 Published : December 11, 2014 Abstract The current view of cancer progression highlights that cancer cells must undergo through a post-translational regulation and metabolic reprogramming to progress in an unfriendly environment. In here, the importance of neddylation modification in liver cancer was investigated. We found that hepatic neddylation was specifically enriched in liver cancer patients with bad prognosis. In addition, the treatment with the neddylation inhibitor MLN4924 in Phb1 -KO mice, an animal model of hepatocellular carcinoma showing elevated neddylation, reverted the malignant phenotype. Tumor cell death in vivo translating into liver tumor regression was associated with augmented phosphatidylcholine synthesis by the PEMT pathway, known as a liver-specific tumor suppressor, and restored mitochondrial function and TCA cycle flux. Otherwise, in protumoral hepatocytes, neddylation inhibition resulted in metabolic reprogramming rendering a decrease in oxidative phosphorylation and concomitant tumor cell apoptosis. Moreover, Akt and LKB1, hallmarks of proliferative metabolism, were altered in liver cancer being new targets of neddylation. Importantly, we show that neddylation-induced metabolic reprogramming and apoptosis were dependent on LKB1 and Akt stabilization. Overall, our results implicate neddylation/signaling/metabolism, partly mediated by LKB1 and Akt, in the development of liver cancer, paving the way for novel therapeutic approaches targeting neddylation in hepatocellular carcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.3191

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 87

Metadata

Authors
Barbier-Torres, L., Delgado, T. C., García-Rodríguez, J. L., Zubiete-Franco, I., Fernández-Ramos, D., Buqué, X., Cano, A., Juan, V. G.-D., Fernández-Domínguez, I., Lopitz-Otsoa, F., Fernández-Tussy, P., Boix, L., Bruix, J., Villa, E., Castro, A., Lu, S. C., Aspichueta, P., Xirodimas, D., Varela-Rey, M., Mato, J. M., Beraza, N., & Martínez-Chantar, M. L.
Venue
Oncotarget
Published
2014-12-11
Volume
6
Issue
4
Pages
2509-2523
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1598608016
Cited by
87
References
8
FWCI
1.58
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. https://app.cochat.ai/papers/10.18632/oncotarget.3191
The paper
Barbier-Torres, L., Delgado, T. C., García-Rodríguez, J. L., Zubiete-Franco, I., Fernández-Ramos, D., Buqué, X., Cano, A., Juan, V. G.-D., Fernández-Domínguez, I., Lopitz-Otsoa, F., Fernández-Tussy, P., Boix, L., Bruix, J., Villa, E., Castro, A., Lu, S. C., Aspichueta, P., Xirodimas, D., Varela-Rey, M., . . . Martínez-Chantar, M. L. (2015). Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. Oncotarget. https://doi.org/10.18632/oncotarget.3191

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.